Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Repeat FX006 (Zilretta) in Knee Osteoarthritis
NCT03046446Phase 3Completed
- Sponsor
- Pacira BioSciences
- Start
- Feb 2017
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Feb 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03046446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03046446.